Presidential Science Council Has Low Profile But Lofty Objectives

Some observers laud body's work to date; others await evidence of true progress Despite President Bill Clinton's headline-grabbing political hassles and the furor surrounding the White House's campaign to enact health-care reform, his comparatively low-profile National Science and Technology Council -- a Cabinet-level policy body he formed late last year -- is functioning undaunted. So far this year, the 16-member panel, composed

Written byBarton Reppert
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Despite President Bill Clinton's headline-grabbing political hassles and the furor surrounding the White House's campaign to enact health-care reform, his comparatively low-profile National Science and Technology Council -- a Cabinet-level policy body he formed late last year -- is functioning undaunted.

So far this year, the 16-member panel, composed of the administration's highest officials and created to provide oversight and interagency coordination of United States research programs, has convened two major science policy forums in Washington, D.C., attended by hundreds of prominent scientists. One of the forums focused on determining strategies for maintaining America's leadership in basic science, mathematics, and engineering; the other centered on environmental and natural resources R&D.

The 16 members of the National Science and Technology Council

Besides Clinton, the council includes Vice President Al Gore, presidential science adviser John H. Gibbons, several Cabinet secretaries, administrators, chiefs of the major independent science agencies, and high-level advisers (see ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies